Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 2

Status

Completed 8Unknown 7Recruiting 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 7

Conditions

Rectal Neoplasms 3Colorectal Neoplasms 2Liver Metastasis Colon Cancer 1Colonic Neoplasms 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Unknown × FOLFOXIRI protocol × Clear all
NCT03484195 2021-04-19

Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer

China Medical University, China

Phase 2 Unknown
30 enrolled
Gastrointestinal

Colonic Neoplasms

NCT03487939 2021-04-19

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

China Medical University, China

Phase 2 Unknown
30 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03484221 2021-04-14

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

China Medical University, China

Phase 2 Unknown
30 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04838496 2021-04-09

MEND-IT

Catharina Ziekenhuis Eindhoven

Phase 2 Unknown
128 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04832776 2021-04-06

FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases

Fudan University

Phase 2 Unknown
160 enrolled
Gastrointestinal

Liver Metastasis Colon Cancer

NCT02942563 2018-01-03

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

RenJi Hospital

Phase 2 Unknown
100 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02128425 2014-05-07

FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer

Sun Yat-sen University

Phase 2 Unknown
162 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡